SHA 100. Prevalence of depression in adult Saudi patients with heart failure, King Abdulaziz Medical City – Riyadh  by Ali, Dalia et al.
improved to 78% at follow-up (P< 0.03). LDL cholesterol
<1.8 mmol/L was achieved in 32%, in contrast to 40% at fol-
low-up (P< 0.044). Twenty-three percent of patients at baseline
had their glycated hemoglobin <0.070, improved to 33% at fol-
low-up (P< 0.004). Prescription of beta blockers declined from
97% at enrollment to 90% at follow-up (P< 0.002). Utilization
of lipid lowering agents was 98% with no change after follow up
(P= 1).
Conclusion: Nurse-led CVDMP in KAMC was effective
in controlling cardiovascular risk factors in patients with
CAD and adheres to utilization of evidence based CAD
medications.
doi:10.1016/j.jsha.2011.02.100
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Background: Depression is a common co-morbid condition in
patients with heart failure (HF). Most studies have been done in
Western populations; there are currently no studies on depression
prevalence in HF patients in Saudi Arabia.
Objectives: To explore the prevalence of depression in the adult
Saudi population with HF attending the nurse led clinic at King
Abdulaziz Medical City.
Methods: A retrospective study was carried out included 148
patients with completed electronic data, and patient health ques-
tionnaire (PHQ). All patients were attending the nurse led HF
clinic at KAMC and had at least one visit from May 2010 to Octo-
ber 2010. Depression was assessed using the validated and Arabic
version of the (PHQ).
Results: A total of 72% of the population were male, 32% of
patients experienced varying degrees of depression: 67% with mild,
19%moderate, 8%moderate to severe and 6% with severe depres-
sion. Depression present in 54% of females and 24% of males.
Conclusion: The prevalence of depression in patients with HF
who followed in nurse led clinic is 32.4% and it’s more prevalent
in females.
doi:10.1016/j.jsha.2011.02.101
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Background: There is intense interest in the use of high-sensitiv-
ity C-reactive protein (hsCRP) for risk assessment. Elevated
hsCRP concentrations early in acute coronary syndrome (ACS),
prior to the tissue necrosis, may be a surrogate marker for cardio-
vascular co-morbidities.
Objective: Therefore we aimed to study different follow up
measurements of hsCRP levels in acute coronary syndrome pa-
tients and to compare the difference between non-ST elevation
myocardial infarction (NSTEMI) and ST myocardial infarction
(STEMI) patients.
Methods: This is an observational study. Of the 89 patients re-
cruited 60 patients had acute myocardial infarction (AMI). Three
serial hsCRP levels at baseline on admission to hospital before
12 h of symptom onset, peak levels at 36–48 h and follow up levels
after 4–6 weeks were analyzed and compared between non-ST ele-
vation AMI and ST elevation AMI.
Results: STEMI patients had signiﬁcantly higher BMI
compared to NSTEMI patients. Creatine kinase myocardial
bound (CKMB) and aspartate aminotransferase (AST) levels were
signiﬁcantly higher in STEMI patients compared to NSTEMI pa-
tients (p= 0.0421). Peak CRP levels were signiﬁcantly higher in
STEMI group compared to NSTEMI group respectively
(22.91 ± 3.23 vs 13.55 ± 3.09, p= 0.0464). While the difference
in baseline (15.93 ± 2.73 vs 10.60 ± 3.08, p= 0.2152) and follow
up (7.87 ± 1.79 vs 10.13 ± 2.83, p= 0.4686) levels between the
two groups was not signiﬁcant.
Conclusion: STEMI patients have signiﬁcantly higher peak
CRP levels compared to NSTEMI patients. These data suggest
that inﬂammatory processes play an independent role in the path-
ogenesis of myocardial infarction. Thus, CRP assessment may as-
sist in risk stratiﬁcation after myocardial infarction.
doi:10.1016/j.jsha.2011.02.102
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Background: There is intense interest in the use of high sensitiv-
ity C-reactive protein (hsCRP), coagulation and ﬁbrinolysis mark-
ers for cardiovascular risk assessment.
Objective: The aim of our study was to compare levels of tissue
plasminogen activator and plasminogen activator inhibitor-1 levels
in patients with acute myocardial infarction and unstable angina.
Methods: Circulating concentrations of high sensitivity C-reac-
tive protein (hsCRP), ﬁbrinogen, tissue-type plasminogen activa-
tor (tPA), and plasminogen activator inhibitor-1 (PAI-1) were
compared between patients of acute myocardial infarction
(AMI) (n= 67), unstable angina pectoris (n= 35) and healthy
control subjects (n= 39).
Results: CAD patients had signiﬁcantly higher hsCRP
(1.06 ± 0.11 vs 0.52 ± 0.14, p< 0.01), ﬁbrinogen (426.21 ±
24.09 vs 329.32 ± 13.93, p< 0.05), PAI-1 (44.02 ± 6.05 vs
19.35 ± 3.94, p< 0.01) and tPA (12.31 ± 1.16 vs 9.49 ± 0.86,
p< 0.05) compared to controls. Fibrinogen (329.32 ± 13.93)
and PAI-1 (19.35 ± 3.94) were higher in both UA and AMI groups
compared to healthy subjects (p< 0.01). In UA and AMI patients
difference between ﬁbrinogen (449.60 ± 52.98 vs 419.46 ± 23.42)
and PAI-1 (52.00 ± 17.34 vs 43.19 ± 6.10) levels were nonsigniﬁ-
cant. Also the difference in tPA levels between control and UA
group was nonsigniﬁcant (9.49 ± 0.86 vs 9.91 ± 1.24, p> 0.05).
It was higher in AMI group (14.79 ± 3.14) compared to UA and
control subjects (p< 0.05). hsCRP levels were signiﬁcantly higher
in both CAD groups (0.52 ± 0.14, 1.05 ± 0.28, 1.40 ± 0.20,
p< 0.01) compared to controls. Moreover, hsCRP levels were sig-
niﬁcantly higher in AMI than UA patients (p< 0.05).
Conclusions: CAD patients have a procoagulant state and pres-
ent with higher levels of hsCRP compared to healthy individuals.
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